Anti Hiv Medicines

Product Details:

Composition & Form

• Active Ingredient: Daclatasvir Dihydrochloride, 60 mg per film-coated tablet

• Form: Oral tablet, available in bottles of 28 tablets. 

• Manufacturer

   

  • Aprazer Healthcare (also marketed under Aprazer/Natco joint branding).

  • Therapeutic Indication

     

    • Indicated for the treatment of chronic Hepatitis C virus (HCV) infection

    • Should be administered in combination with Sofosbuvir (400 mg), typically for a 12‑week regimen.

    • Mechanism of Action

       

      • Direct‑acting antiviral (NS5A inhibitor) that disrupts HCV replication, reducing viral load and aiding liver recovery.

      • Dosage & Administration

         

        • One tablet (60 mg) orally once daily

        • Can be taken with or without food

        • For best results, take at the same time each day for the full prescribed duration—usually 12 weeks.

        • Key Benefits

           

          • Facilitates elimination of HCV, improving patients’ immune and liver health

          • Helps reduce the risk of progression to liver cirrhosis and hepatocellular carcinoma.

          • Precautions & Warnings

             

            • Prescription-only medication — ensure patient evaluation before dispensing

            • Monitor liver and kidney function during treatment.

            • Avoid use during pregnancy and breastfeeding unless clearly indicated; advised to use contraception

            • May cause side effects such as headache, dizziness, nausea, fatigue; avoid driving or operating machinery if affected

             

            • Caution with cardiac drugs like amiodarone and with CYP3A inducers/inhibitors.

            • Packaging & Storage

               

              • Bottles containing 28 tablets (60 mg)

              • Store at room temperature, protected from moisture and direct sunlight.

              • Trade & Export

                 

                • Supplied by Aprazer Healthcare

                • Export capacity supported, suitable for global markets including India, Middle East, Africa, Europe, and America.

Product Details:

Product Name: Acriptega (Dolutegravir, Lamivudine, and Tenofovir Tablets 50mg/300mg/300mg)

Generic Name: Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate Tablets

Composition:

• Dolutegravir 50 mg

• Lamivudine 300 mg

• Tenofovir Disoproxil Fumarate 300 mg

Brand Name: Acriptega

Manufacturer: [Insert Manufacturer Name, e.g., ViiV Healthcare / Mylan Laboratories Ltd.]

Packaging: Bottle of 30 Tablets

Indication:
Acriptega is a fixed-dose combination antiretroviral medication used in the treatment of HIV-1 infection in adults and adolescents. It helps to reduce viral load, improve immune function, and delay progression of HIV infection.

Dosage:
As directed by a healthcare professional.

Key Features:

• Once-daily complete regimen for HIV-1 treatment

• High efficacy and good tolerability

• WHO-approved formulation

• Convenient fixed-dose combination

Storage:
Store below 30°C. Protect from moisture and direct sunlight.

Minimum Order Quantity (MOQ): [Insert MOQ, e.g., 1 Bottle / 100 Bottles]

Country of Origin: India